Evaluation of Inappropriate COVID-19 RT-PCR Test Utilization at an Academic Medical Center.
JournalJournal of Applied Laboratory Medicine
PublisherOxford University Press
MetadataShow full item record
AbstractBACKGROUND: An evolving COVID-19 testing landscape and issues with test supply allocation, especially in the current pandemic, has made it challenging for ordering providers. We audited orders of the Xpert® Xpress SARS-CoV-2 PCR with reverse transcription (RT-PCR) platform-the fastest of several other testing modalities available-to illuminate these challenges utilizing a multidisciplinary laboratory professional team consisting of a pathology resident and microbiology laboratory director. METHODS: Retrospective review of the first 5 hundred Xpert Xpress SARS-CoV-2 RT-PCR test orders from a 2-week period to determine test appropriateness based on the following indications: emergency surgery, emergent obstetric procedures, initial behavioral health admission, and later including discharge to skilled care facilities and pediatric admissions. Our hypothesis was that a significant proportion of orders for this testing platform were inappropriate. RESULTS: On review, a significant proportion of orders were incorrect, with 69.8% (n = 349, P < 0.0001) not meeting indications for rapid testing. Of all orders, 249 designated as emergency surgery were inappropriate, with 49.0% of those orders never proceeding with any surgical intervention; most of these were trauma related (64.6% were orders associated with a trauma unit). CONCLUSIONS: Significant, pervasive inappropriate ordering practices were identified at this center. A laboratory professional team can be key to identifying problems in testing and play a significant role in combating inappropriate test utilization.
Rights/Terms© American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: email@example.com.
laboratory methods and tools
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/17573
- Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
- Authors: Wolters F, van de Bovenkamp J, van den Bosch B, van den Brink S, Broeders M, Chung NH, Favié B, Goderski G, Kuijpers J, Overdevest I, Rahamat-Langedoen J, Wijsman L, Melchers WJ, Meijer A
- Issue date: 2020 Jul
- Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay.
- Authors: Graham M, Williams E, Isles N, Buadromo E, Toatu T, Druce J, Catton M, Lin C, Howden BP, Williamson DA
- Issue date: 2021 Feb
- A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
- Authors: Brakenhoff TB, Franks B, Goodale BM, van de Wijgert J, Montes S, Veen D, Fredslund EK, Rispens T, Risch L, Dowling AV, Folarin AA, Bruijning P, Dobson R, Heikamp T, Klaver P, Cronin M, Grobbee DE, COVID-RED Consortium.
- Issue date: 2021 Oct 11
- Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
- Authors: Lee J, Song JU
- Issue date: 2021 Jul
- Validation of GeneXpert testing for SARS-CoV-2 RNA in eight hospital laboratories in Oman.
- Authors: Al-Kindi N, Al-Shukri I, Al-Rashdi A, Al-Siyabi N, Al Mahruqi S, Al-Kindi H, Al-Jardani A
- Issue date: 2021